| Margins | Consolidated EBITDA margin at 31.0%; PAT margin at 26.1%. |
|---|---|
| Demand visibility | Bank credit growth accelerated to 18.6% as of June 2026. |
Growth
Consolidated PAT grew 24.6% YoY to Rs. 32.99 Cr; Ratings business revenue rose 19.1% YoY.
Outlook
Focus on AI-embedded products (EdgeAvira.AI) and global sovereign ratings coverage; non-ratings business grew 17.9%.
Risks
Corporate bond issuances declined 29.3% YoY due to global market uncertainties and elevated yields.
Earnings Call Transcript filed with NSE, NSE: CARERATING. Summary written with AI assistance from the document.
CARE Ratings Ltd: key numbers
- Share price
- ₹1,588.20
- Market cap
- ₹4,786 Cr
- Revenue (annual)
- ₹473.1 Cr
- Net profit (annual)
- ₹171.2 Cr
- P/E (TTM)
- 26.9×Sector 21.9×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 23.41%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from CARE Ratings Ltd
All →CARE Ratings Earnings Call Transcript: Key Takeaways
CARE Ratings Q1 FY27 presentation highlights 18.9% consolidated revenue growth and 24.6% PAT growth. Expansion into global sovereign ratings and ESG services drives non-ratings momentum.
CARE Ratings Employee Stock Options
CARE Ratings has allotted 24,500 equity shares to employees following the exercise of options under its Employee Stock Option Scheme 2020.
CARE Ratings Results Update
CARE Ratings Limited reported its Q1 FY27 results, highlighting strong standalone revenue growth of 16.5% YoY and consolidated revenue growth of 18.9% YoY.
CARE Ratings Q1 FY27 Results: Net Profit ₹33 Cr, Up 24.5% YoY
CARE Ratings Ltd reported revenue from operations of ₹111.7 Cr (+19.0% YoY) and net profit of ₹33 Cr (+24.5% YoY) for Q1 FY27.
- Key figure
- Net profit ₹33 Cr · +24.5% YoY
CARE Ratings Employee Stock Options
CARE Ratings Limited allotted 6,766 equity shares to employees upon the exercise of stock options under its ESOP scheme.
CARE Ratings Board Meeting Date
CARE Ratings will hold a board meeting on August 7, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.